Prospective clinical validation of a highly accurate breast cancer diagnostic test that determines effective personalized treatment, predicts response to therapy and disease prognosis. The aim is to drastically reduce the number of non-responders and relapse rates of bladder cancer by ca. 50% and save thousands of lives each year. ReferenceSK-C[C9]-I[I1]Project locations Slovakia Project websitehttps://www.multiplexdx.com/
